The following discussion is designed to provide a better understanding of our
Unaudited Consolidated Financial Statements for the three months ended March 31,
2023, including a brief discussion of our business, key factors that impacted
our performance and a summary of our operating results. The following discussion
should be read in conjunction with the Unaudited Consolidated Financial
Statements and the notes thereto included in Item 1 of this Quarterly Report on
Form 10-Q, and the Consolidated Financial Statements and notes thereto and
Management's Discussion and Analysis of Financial Condition and Results of
Operations contained in our Annual Report on Form 10-K for the year ended
December 31, 2022. Historical results and percentage relationships among any
amounts in the financial statements are not necessarily indicative of trends in
operating results for any future periods.

Forward-Looking Statements



Some of the statements in this Quarterly Report constitute forward-looking
statements because they relate to future events or our future performance or
financial condition. Forward-looking statements may include, among other things,
statements as to our future operating results, our business prospects and the
prospects of our portfolio companies, the impact of the investments that we
expect to make, the ability of our portfolio companies to achieve their
objectives, our expected financings and investments, the adequacy of our cash
resources and working capital, and the timing of cash flows, if any, from the
operations of our portfolio companies. Words such as "expect," "anticipate,"
"target," "goals," "project," "intend," "plan," "believe," "seek," "estimate,"
"continue," "forecast," "may," "should," "potential," variations of such words,
and similar expressions indicate a forward-looking statement, although not all
forward-looking statements include these words. Readers are cautioned that the
forward-looking statements contained in this Quarterly Report are only
predictions, are not guarantees of future performance, and are subject to risks,
events, uncertainties and assumptions that are difficult to predict. Our actual
results could differ materially from those implied or expressed in the
forward-looking statements for any reason, including the items discussed herein,
in Item 1A entitled "Risk Factors" in Part I of our Annual Report on Form 10-K
for the year ended December 31, 2022 and in Item 1A entitled "Risk Factors" in
Part II of our subsequently filed Quarterly Reports on Form 10-Q or in other
reports that we may file with the Securities and Exchange Commission (the "SEC")
from time to time. Other factors that could cause our actual results and
financial condition to differ materially include, but are not limited to,
changes in political, economic or industry conditions, including the risks of a
slowing economy, rising inflation and risk of recession, and volatility in the
financial services sector, including bank failures; the interest rate
environment or conditions affecting the financial and capital markets; the
impact of global health crises, on our or our portfolio companies' business and
the U.S. and global economies; our, or our portfolio companies', future
business, operations, operating results or prospects; risks associated with
possible disruption due to terrorism in our operations or the economy generally;
and future changes in laws or regulations and conditions in our or our portfolio
companies' operating areas. These statements are based on our current
expectations, estimates, forecasts, information and projections about the
industry in which we operate and the beliefs and assumptions of our management
as of the date of filing of this Quarterly Report. We assume no obligation to
update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise, unless we are required to do so by law.
Although we undertake no obligation to revise or update any forward-looking
statements, whether as a result of new information, future events or otherwise,
you are advised to consult any additional disclosures that we may make directly
to you or through reports that we in the future may file with the SEC, including
annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports
on Form 8-K.

Overview of Our Business

We are a Maryland corporation incorporated on October 10, 2006. In August 2018,
in connection with the closing of an externalization transaction through which
Barings LLC ("Barings" or the "Adviser") agreed to become our external
investment adviser, we entered into an investment advisory agreement (the
"Original Advisory Agreement") and an administration agreement (the
"Administration Agreement") with Barings. In connection with the completion of
our acquisition of MVC Capital, Inc., a Delaware corporation, on December 23,
2020 (the "MVC Acquisition"), we entered into an amended and restated investment
advisory agreement (the "Amended and Restated Advisory Agreement") with Barings
on December 23, 2020, following approval of the Amended and Restated Advisory
Agreement by our stockholders at our December 23, 2020 special meeting of
stockholders. The terms of the Amended and Restated Advisory Agreement became
effective on January 1, 2021. In connection with the completion of the Sierra
Merger (as defined below), on February 25, 2022, we entered into a second
amended and restated investment advisory agreement (the "New Barings BDC
Advisory Agreement") with the Adviser. Under the terms of the New Barings BDC
Advisory Agreement and the Administration Agreement, Barings serves as our
investment adviser and administrator and manages our investment portfolio and
performs (or oversees, or arranges for, the performance of) the administrative
services necessary for our operation.
                                      112
--------------------------------------------------------------------------------


An externally-managed BDC generally does not have any employees, and its
investment and management functions are provided by an outside investment
adviser and administrator under an advisory agreement and administration
agreement. Instead of directly compensating employees, we pay Barings for
investment management and administrative services pursuant to the terms of an
investment advisory agreement and an administration agreement. Under the terms
of the New Barings BDC Advisory Agreement, the fees paid to Barings for managing
our affairs are determined based upon an objective and fixed formula, as
compared with the subjective and variable nature of the costs associated with
employing management and employees in an internally-managed BDC structure, which
include bonuses that cannot be directly tied to Company performance because of
restrictions on incentive compensation under the Investment Company Act of 1940,
as amended (the "1940 Act").

Beginning in August 2018, Barings shifted our investment focus to invest in
syndicated senior secured loans, bonds and other fixed income securities. Since
that time, Barings has transitioned our portfolio to primarily senior secured
private debt investments in well-established middle-market businesses that
operate across a wide range of industries. Barings' existing SEC co-investment
exemptive relief under the 1940 Act (the "Exemptive Relief") permits us and
Barings' affiliated private and SEC-registered funds to co-invest in
Barings-originated loans, which allows Barings to efficiently implement its
senior secured private debt investment strategy for us.

Barings employs fundamental credit analysis, and targets investments in
businesses with relatively low levels of cyclicality and operating risk. The
holding size of each position will generally be dependent upon a number of
factors including total facility size, pricing and structure, and the number of
other lenders in the facility. Barings has experience managing levered vehicles,
both public and private, and will seek to enhance our returns through the use of
leverage with a prudent approach that prioritizes capital preservation. Barings
believes this strategy and approach offers attractive risk/return with lower
volatility given the potential for fewer defaults and greater resilience through
market cycles. A significant portion of our investments are expected to be rated
below investment grade by rating agencies or, if unrated would be rated below
investment grade if they were rated. Below investment grade securities, which
are often referred to as "junk," have predominantly speculative characteristics
with respect to the issuer's capacity to pay interest and repay principal.

We generate revenues in the form of interest income, primarily from our
investments in debt securities, loan origination and other fees and dividend
income. Fees generated in connection with our debt investments are recognized
over the life of the loan using the effective interest method or, in some cases,
recognized as earned. Our senior secured, middle-market, private debt
investments generally have terms of between five and seven years. Our senior
secured, middle-market, first lien private debt investments generally bear
interest between the Secured Overnight Financing Rate ("SOFR") (or the
applicable currency rate for investments in foreign currencies) plus 475 basis
points and SOFR plus 675 basis points per annum. Our subordinated middle-market,
private debt investments generally bear interest between LIBOR (or the
applicable currency rate for investments in foreign currencies) plus 700 basis
points and LIBOR plus 900 basis points per annum if floating rate, and between
8% and 15% if fixed rate. From time to time, certain of our investments may have
a form of interest, referred to as payment-in-kind, or PIK, interest, which is
not paid currently but is instead accrued and added to the loan balance and paid
at the end of the term.

As of March 31, 2023 and December 31, 2022, the weighted average yield on the
principal amount of our outstanding debt investments other than non-accrual debt
investments was approximately 10.2% and 9.7%, respectively. The weighted average
yield on the principal amount of all of our outstanding debt investments
(including non-accrual debt investments) was approximately 9.5% and 9.1% as of
March 31, 2023 and December 31, 2022, respectively.

Sierra Income Corporation Acquisition



On February 25, 2022, we completed our acquisition of Sierra Income Corporation,
a Maryland corporation ("Sierra"), pursuant to the terms and conditions of that
certain Agreement and Plan of Merger (the "Sierra Merger Agreement"), dated as
of September 21, 2021, with Sierra, Mercury Acquisition Sub, Inc., a Maryland
corporation and our direct wholly owned subsidiary ("Sierra Acquisition Sub"),
and Barings. To effect the acquisition, Sierra Acquisition Sub merged with and
into Sierra, with Sierra surviving the merger as our wholly owned subsidiary
(the "First Sierra Merger"). Immediately thereafter, Sierra merged with and into
us, with Barings BDC, Inc. as the surviving company (the "Second Sierra Merger"
and, together with the First Sierra Merger, the "Sierra Merger").

Pursuant to the Sierra Merger Agreement, each share of Sierra common stock, par
value $0.001 per share (the "Sierra Common Stock"), issued and outstanding
immediately prior to the effective time of the First Sierra Merger (other than
shares of Sierra Common Stock issued and outstanding immediately prior to the
effective time of the First Sierra Merger that were held by a subsidiary of
Sierra or held, directly or indirectly, by us or Sierra Acquisition Sub) was
converted into the right to receive (i) an amount in cash from Barings, without
interest, equal to $0.9783641, and (ii) 0.44973 shares of our common stock, plus
any cash in lieu of fractional shares. As a result of the Sierra Merger, former
Sierra stockholders received approximately 46.0 million shares of our common
stock for their shares of Sierra Common Stock.
                                      113
--------------------------------------------------------------------------------


In connection with the Sierra Merger, on February 25, 2022, following the
closing of the Sierra Merger, we entered into (1) the New Barings BDC Advisory
Agreement, and (2) a credit support agreement (the "Sierra Credit Support
Agreement") with Barings, pursuant to which Barings has agreed to provide credit
support to us in the amount of up to $100.0 million relating to the net
cumulative realized and unrealized losses on the acquired Sierra investment
portfolio over a 10-year period. See "Note 2. Agreements and Related Party
Transactions" and "Note. 6 Derivative Instruments" in the Notes to our Unaudited
Consolidated Financial Statements included in this Quarterly Report on Form 10-Q
for more information.

In addition, in connection with the Sierra Merger, we committed to make
open-market purchases of our common stock, pursuant to Rule 10b-18 under the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), and subject to
our compliance with our covenant and regulatory requirements, shares of our
common stock in an aggregate amount of up to $30.0 million at then-current
market prices at any time the shares of our common stock trade below 90% of our
then most recently disclosed net asset value per share during the 12-month
period commencing on April 1, 2022.

Relationship with Our Adviser, Barings



Our investment adviser, Barings, a wholly-owned subsidiary of Massachusetts
Mutual Life Insurance Company, is a leading global asset management firm and is
registered with the SEC as an investment adviser under the Investment Advisers
Act of 1940, as amended. Barings' primary investment capabilities include fixed
income, private credit, real estate, equity, and alternative investments.
Subject to the overall supervision of the Board, Barings' Global Private Finance
Group ("Barings GPFG") manages our day-to-day operations, and provides
investment advisory and management services to us. Barings GPFG is part of
Barings' $281.6 billion Global Fixed Income Platform (as of March 31, 2023) that
invests in liquid, private and structured credit. Barings GPFG manages private
funds and separately managed accounts, along with multiple public vehicles.

Among other things, Barings (i) determines the composition of our portfolio, the
nature and timing of the changes therein and the manner of implementing such
changes; (ii) identifies, evaluates and negotiates the structure of the
investments made by us; (iii) executes, closes, services and monitors the
investments that we make; (iv) determines the securities and other assets that
we will purchase, retain or sell; (v) performs due diligence on prospective
portfolio companies and (vi) provides us with such other investment advisory,
research and related services as we may, from time to time, reasonably require
for the investment of our funds.

Under the terms of the Administration Agreement, Barings (in its capacity as our
Administrator) performs (or oversees, or arranges for, the performance of) the
administrative services necessary for our operation, including, but not limited
to, office facilities, equipment, clerical, bookkeeping and record keeping
services at such office facilities and such other services as Barings, subject
to review by the Board, will from time to time determine to be necessary or
useful to perform its obligations under the Administration Agreement. Barings
also, on our behalf and subject to the Board's oversight, arranges for the
services of, and oversees, custodians, depositories, transfer agents, dividend
disbursing agents, other stockholder servicing agents, accountants, attorneys,
underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and
such other persons in any such other capacity deemed to be necessary or
desirable. Barings is responsible for the financial and other records that we
are required to maintain and will prepare all reports and other materials
required to be filed with the SEC or any other regulatory authority.

Included in Barings GPFG is Barings North American Private Finance Team (the
"U.S. Investment Team"), which consists of 51 investment professionals (as of
March 31, 2023) located in three offices in the U.S. The U.S. Investment Team
provides a full set of solutions to the North American middle market, including
revolvers, first and second lien senior secured loans, unitranche structures,
mezzanine debt and equity co-investments. The U.S. Investment Team averages over
20 years of industry experience at the Managing Director and Director level. In
addition, Barings believes that it has best-in-class support personnel,
including expertise in risk management, legal, accounting, tax, information
technology and compliance, among others. We expect to benefit from the support
provided by these personnel in our operations.

Stockholder Approval of Reduced Asset Coverage Ratio



On July 24, 2018, our stockholders voted at a special meeting of stockholders
(the "2018 Special Meeting") to approve a proposal to authorize us to be subject
to a reduced asset coverage ratio of at least 150% under the 1940 Act. As a
result of the stockholder approval at the 2018 Special Meeting, effective July
25, 2018, our applicable asset coverage ratio under the 1940 Act has been
decreased to 150% from 200%. As a result, we are permitted under the 1940 Act to
incur indebtedness at a level which is more consistent with a portfolio of
senior secured debt. As of March 31, 2023, our asset coverage ratio was 180.8%.
                                      114
--------------------------------------------------------------------------------

Portfolio Composition



The total value of our investment portfolio was $2,556.1 million as of March 31,
2023, as compared to $2,448.9 million as of December 31, 2022. As of March 31,
2023, we had investments in 331 portfolio companies with an aggregate cost of
$2,658.5 million. As of December 31, 2022, we had investments in 322 portfolio
companies with an aggregate cost of $2,562.4 million. As of both March 31, 2023
and December 31, 2022, none of our portfolio investments represented greater
than 10% of the total fair value of our investment portfolio.

As of March 31, 2023 and December 31, 2022, our investment portfolio consisted of the following investments:


                                                                  Percentage of                                       Percentage of
                                                                      Total                                               Total
($ in thousands)                             Cost                   Portfolio                 Fair Value                Portfolio
March 31, 2023:
Senior debt and 1st lien notes          $ 1,813,687                             68  %       $ 1,765,238                             69  %
Subordinated debt and 2nd lien notes        318,480                             12              255,089                             10
Structured products                          96,896                              4               79,343                              3
Equity shares                               274,704                             10              331,880                             13
Equity warrants                                 178                              -                1,056                              -
Investment in joint ventures / PE fund      154,539                              6              123,508                              5

                                        $ 2,658,484                            100  %       $ 2,556,114                            100  %
December 31, 2022:
Senior debt and 1st lien notes          $ 1,752,943                             69  %       $ 1,696,192                             69  %
Subordinated debt and 2nd lien notes        326,639                             13              263,139                             11
Structured products                          88,805                              3               73,550                              3
Equity shares                               230,188                              9              284,570                             12
Equity warrants                                 178                              -                1,057                              -
Investment in joint ventures / PE fund      163,645                              6              130,427                              5

                                        $ 2,562,398                            100  %       $ 2,448,935                            100  %

Investment Activity



During the three months ended March 31, 2023, we made 11 new investments
totaling $65.8 million, made investments in existing portfolio companies
totaling $33.9 million and made a $45.0 million equity co-investment alongside
certain affiliates in a portfolio company that specializes in providing
financing to plaintiff law firms engaged in mass tort and other civil
litigation. We had four loans repaid totaling $26.6 million, received $12.7
million of portfolio company principal payments and received $9.1 million of
return of capital from our joint ventures. In addition, we sold $1.0 million of
loans, recognizing a net realized loss on these transactions of $0.3 million. We
received proceeds related to the sale of equity investments totaling $4.3
million and recognized a net realized gain on such sales totaling $1.0 million.

During the three months ended March 31, 2022, we made 22 new investments
totaling $229.3 million, purchased $442.2 million of investments as part of the
Sierra Merger, made investments in existing portfolio companies totaling $89.3
million and made additional investments in joint venture equity portfolio
companies totaling $11.7 million. We had four loans repaid totaling $12.4
million and received $7.5 million of portfolio company principal payments. In
addition, we sold $19.2 million of loans, recognizing a net realized gain on
these transactions of $0.8 million, and sold $132.3 million of middle-market
portfolio company debt investments to one of our joint ventures and realized a
loss on these transactions of $0.2 million. Lastly, we received proceeds related
to the sale of equity investments totaling $1.6 million and recognized a net
realized loss on such sales totaling $0.7 million.
                                      115
--------------------------------------------------------------------------------


Total portfolio investment activity for the three months ended March 31, 2023
and 2022 was as follows:
Three Months Ended                 Senior Debt                                                                                                Investments in
March 31, 2023:                   and 1st Lien         Subordinated Debt          Structured             Equity             Equity           Joint Ventures /
($ in thousands)                      Notes            and 2nd Lien Notes          Products              Shares            Warrants              PE Fund                       Total

Fair value, beginning of period $ 1,696,192 $ 263,139

    $     73,550          $ 284,570          $   1,057          $       130,427                $ 2,448,935
New investments                        86,805                      769                 9,382             47,763                  -                        -                    144,719

Proceeds from sales of
investments/return of capital            (979)                       -                  (902)            (4,297)                 -                   (9,106)                   (15,284)
Loan origination fees received         (2,397)                     (23)                    -                  -                  -                        -                     (2,420)
Principal repayments received         (26,475)                 (11,445)                 (394)                 -                  -                        -                    (38,314)
Payment-in-kind
interest/dividend                       1,974                    2,319                     -                  -                  -                        -                         4,293
Accretion of loan
premium/discount                          243                       55                     5                  -                  -                        -                        303
Accretion of deferred loan
origination revenue                     1,856                      161                     -                  -                  -                        -                      2,017
Realized gain (loss)                       (282)                        4                     -              1,049                  -                        -                     771
Unrealized appreciation
(depreciation)                             8,301                      110               (2,298)              2,795                (1)                    2,187                  11,094

Fair value, end of period $ 1,765,238 $ 255,089

    $     79,343          $ 331,880          $   1,056          $       123,508                $ 2,556,114



Three Months Ended                 Senior Debt                                                                                                Investments in
March 31, 2022:                   and 1st Lien         Subordinated Debt          Structured             Equity             Equity           Joint Ventures /
($ in thousands)                      Notes            and 2nd Lien Notes          Products              Shares            Warrants              PE Fund                 Total

Fair value, beginning of period $ 1,221,598 $ 240,037

$ 40,271 $ 154,477 $ 1,107 $ 143,104 $ 1,800,594 New investments

                       268,202                   30,065                 1,060             19,200                  -                   11,696              330,223
Investments acquired in Sierra
merger                                235,770                   66,662                46,666              7,065                 72                   85,963              442,198
Proceeds from sales of
investments                          (151,575)                       -                     -             (1,388)              (249)                       -             (153,212)
Loan origination fees received         (5,350)                      36                     -                  -                  -                        -               (5,314)
Principal repayments received          (8,114)                 (11,020)                 (730)                 -                  -                        -              (19,864)
Payment-in-kind
interest/dividend                       1,050                    6,984                     -                  -                  -                        -                8,034
Accretion of loan
premium/discount                          301                       33                     5                  -                  -                        -                  339
Accretion of deferred loan
origination revenue                     1,461                       62                     -                  -                  -                        -                1,523
Realized gain (loss)                         579                        8                     -                 24              (760)                        -              (149)
Unrealized appreciation
(depreciation)                           (8,176)                 (15,224)               (5,258)             40,088               (14)                 (12,363)              (947)

Fair value, end of period $ 1,555,746 $ 317,643

$ 82,014 $ 219,466 $ 156 $ 228,400 $ 2,403,425




Non-Accrual Assets

Generally, when interest and/or principal payments on a loan become past due, or
if we otherwise do not expect the borrower to be able to service its debt and
other obligations, we will place the loan on non-accrual status and will
generally cease recognizing interest income on that loan for financial reporting
purposes until all principal and interest have been brought current through
payment or due to a restructuring such that the interest income is deemed to be
collectible. As of March 31, 2023, we had nine portfolio companies with
investments on non-accrual, the fair value of which was $28.5 million, which
comprised 1.1% of the total fair value of our portfolio, and the cost of which
was $102.3 million, which comprised 3.8% of the total cost of our portfolio. As
of December 31, 2022, we had seven portfolio companies with investments on
non-accrual, the fair value of which was $24.3 million, which comprised 1.0% of
the total fair value of our portfolio, and the cost of which was $98.8 million,
which comprised 3.9% of the total cost of our portfolio.
                                      116
--------------------------------------------------------------------------------

A summary of our non-accrual assets as of March 31, 2023 is provided below:

1888 Industrial Services, LLC



In connection with the Sierra Merger, we purchased our debt and equity
investments in 1888 Industrial Services, LLC, or 1888. The 1888 debt investments
are on non-accrual status and as a result, under U.S. GAAP, we will not
recognize interest income on our debt investments in 1888 for financial
reporting purposes. As of March 31, 2023, the cost of our debt investments in
1888 was $1.9 million and the fair value of such investments was $1.1 million.

Black Angus Steakhouse, LLC



In connection with the Sierra Merger, we purchased our debt and equity
investments in Black Angus Steakhouse, LLC, or Black Angus. The Black Angus PIK
term loan is on non-accrual status and as a result, under U.S. GAAP, we will not
recognize interest income on our PIK term loan in Black Angus for financial
reporting purposes. As of March 31, 2023, the cost of the PIK term loan in Black
Angus was $9.6 million and the fair value of such investment was $8.8 million.

Core Scientific, Inc.



During the quarter ended December 31, 2022, we placed our debt investment in
Core Scientific, Inc., or Core Scientific, on non-accrual status effective with
the monthly payment due October 31, 2022. As a result, under U.S. GAAP, we will
not recognize interest income on our debt investment in Core Scientific for
financial reporting purposes. As of March 31, 2023, the cost of our debt
investment in Core Scientific was $29.6 million and the fair value of such
investment was $15.0 million.

Custom Alloy Corporation



In connection with the MVC Acquisition, we purchased our debt investment in
Custom Alloy Corporation, or Custom Alloy. During the quarter ended December 31,
2021, we placed our debt investment in Custom Alloy on non-accrual status. As a
result, under U.S. GAAP, we will not recognize interest income on our debt
investment in Custom Alloy for financial reporting purposes. As of March 31,
2023, the cost of our debt investment in Custom Alloy was $46.4 million and the
fair value of such investment was $0.9 million.

Holland Acquisition Corp.



In connection with the Sierra Merger, we purchased our debt investment in
Holland Acquisition Corp., or Holland. Holland is on non-accrual status and as a
result, under U.S. GAAP, we will not recognize interest income on our debt
investment in Holland for financial reporting purposes. As of March 31, 2023,
both the cost and fair value of our debt investment in Holland was nil.

Isagenix International, LLC



In connection with the Sierra Merger, we purchased our debt investment in
Isagenix International, LLC, or Isagenix. During the quarter ended September 30,
2022, we placed our debt investment in Isagenix on non-accrual status. As a
result, under U.S. GAAP, we will not recognize interest income on our debt
investment in Isagenix for financial reporting purposes. As of March 31, 2023,
the cost of our debt investment in Isagenix was $1.2 million and the fair value
of such investment was $0.5 million.

Legal Solutions Holdings



In connection with the MVC Acquisition, we purchased our debt investment in
Legal Solutions Holdings, or Legal Solutions. During the quarter ended September
30, 2021, we placed our debt investment in Legal Solutions on non-accrual
status. As a result, under U.S. GAAP, we will not recognize interest income on
our debt investment in Legal Solutions for financial reporting purposes. As of
March 31, 2023, the cost of our debt investment in Legal Solutions was $10.1
million and the fair value of such investment was $39.4 thousand.
                                      117
--------------------------------------------------------------------------------

Serta Simmons Bedding LLC



During the quarter ended March 31, 2023, we placed our Super Priority Second
Out, or Second Out, debt investment in Serta Simmons Bedding LLC, or Serta
Simmons, on non-accrual status effective with the quarterly payment due on March
31, 2023. As a result, under U.S. GAAP, we will not recognize interest income on
our Second Out debt investment in Serta Simmons for financial reporting
purposes. As of March 31, 2023, the cost of our Second Out debt investment in
Serta Simmons was $3.4 million and the fair value of such investments was $2.0
million.

Wawona Delaware Holdings, LLC



In connection with the Sierra Merger, we purchased our debt investment in Wawona
Delaware Holdings, LLC, or Wawona. During the quarter ended March 31, 2023, we
placed our debt investment in Wawona on non-accrual status. As a result, under
U.S. GAAP, we will not recognize interest income on our debt investment in
Wawona for financial reporting purposes. As of March 31, 2023, the cost of our
debt investment in Wawona was $41.0 thousand and the fair value of such
investment was $30.4 thousand.

Results of Operations

Comparison of the three months ended March 31, 2023 and March 31, 2022



Operating results for the three months ended March 31, 2023 and 2022 were as
follows:
                                                                        Three Months           Three Months
                                                                           Ended                  Ended
                                                                         March 31,              March 31,
($ in thousands)                                                            2023                   2022

Total investment income                                               $     

67,204 $ 43,757



Total operating expenses                                                     39,509                 24,742
Net investment income before taxes                                           27,695                 19,015
Income taxes, including excise tax provision                                    195                      6
Net investment income after taxes                                            27,500                 19,009

Net realized gains (losses)                                                  (9,746)                (1,442)

Net unrealized appreciation (depreciation)                                   21,970                  3,465

Benefit from (provision for) taxes                                              (73)                     -
Net increase in net assets resulting from operations                  $     

39,651 $ 21,032

Net increases or decreases in net assets resulting from operations vary substantially from period to period due to various factors, including recognition of realized gains and losses and unrealized appreciation and depreciation. As a result, quarterly comparisons of net increases or decreases in net assets resulting from operations may not be meaningful.



Investment Income

                                           Three Months       Three Months
                                               Ended              Ended
                                             March 31,          March 31,
($ in thousands)                               2023               2022
Investment income:

Total interest income                     $      51,890      $      32,069

Total dividend income                             7,874              7,693

Total fee and other income                        3,300              1,197

Total payment-in-kind interest income             3,942              2,798
Interest income from cash                           198                  -
Total investment income                   $      67,204      $      43,757


The change in total investment income for the three months ended March 31, 2023,
as compared to the three months ended March 31, 2022, was primarily due to an
increase in the weighted average yield on the portfolio from higher base rates,
an increase in the average size of our portfolio, increased dividends from
portfolio companies and joint venture investments and increased payment-in-kind
("PIK") interest income. The weighted average yield on the principal amount of
our outstanding debt investments, other than non-accrual debt investments was
10.2% as of March 31, 2023, as compared to 7.3% as of March 31, 2022. The amount
of our outstanding debt investments was $2,353.1 million as of March 31, 2023,
as compared to $2,134.2 million as of March 31, 2022. The increase in the
average size of our portfolio was largely due to the increased middle-market
investment opportunities and special situation investment opportunities. For
three months ended March 31,
                                      118
--------------------------------------------------------------------------------


2022, the portfolio included the investments acquired as part of the Sierra
Merger; however, as the Sierra Merger did not close until late in the first
quarter of 2022, we did not receive a full quarter of investment income from the
acquired Sierra portfolio for the three months ended March 31, 2022. For the
three months ended March 31, 2023, dividends from portfolio companies and joint
venture investments were $7.9 million, as compared to $7.7 million for the three
months ended March 31, 2022. For the three months ended March 31, 2023,
acceleration of unamortized OID income and unamortized loan origination fees
totaled $0.3 million as compared to $0.2 million for the three months ended
March 31, 2022. For the three months ended March 31, 2023, PIK interest income
was $3.9 million, as compared to $2.8 million for the three months ended
March 31, 2022.

Operating Expenses
                                                Three Months       Three Months
                                                    Ended              Ended
                                                  March 31,          March 31,
         ($ in thousands)                           2023               2022

         Operating expenses:
         Interest and other financing fees     $      19,316      $      11,661
         Base management fees                          7,853              5,872
         Incentive management fees                     9,604              4,754

         General and administrative expenses           2,736              2,455
         Total operating expenses              $      39,509      $      24,742

Interest and Other Financing Fees



Interest and other financing fees during both the three months ended March 31,
2023 and March 31, 2022 were attributable to borrowings under the February 2019
Credit Facility, the August 2025 Notes, the November Notes, the February Notes
and the November 2026 Notes (each as defined below under "Liquidity and Capital
Resources"). The increase in interest and other financing fees for the three
months ended March 31, 2023 as compared to the three months ended March 31,
2022, was primarily attributable to increase in the weighted average interest
rate on the February 2019 Credit Facility. The weighted average interest on the
February 2019 Credit Facility was 6.3% as of March 31, 2023, as compared to 2.2%
as of March 31, 2022.

Base Management Fees

Under the terms of the New Barings BDC Advisory Agreement, we pay Barings a base
management fee (the "Base Management Fee"), quarterly in arrears on a calendar
quarter basis. The Base Management Fee is calculated based on the average value
of our gross assets, excluding cash and cash equivalents, at the end of the two
most recently completed calendar quarters prior to the quarter for which such
fees are being calculated. Base Management Fees for any partial month or quarter
are appropriately pro-rated. See Note 2 to our Unaudited Consolidated Financial
Statements for additional information regarding the terms of the New Barings BDC
Advisory Agreement and the fee arrangements thereunder. For the three months
ended March 31, 2023, the amount of Base Management Fee incurred was
approximately $7.9 million. For the three months ended March 31, 2022, the
amount of Base Management Fee incurred was approximately $5.9 million. The
increase in the Base Management Fee for the three months ended March 31, 2023
versus the corresponding 2022 period is primarily related to the average value
of gross assets increasing from $1,879.0 million as of the end of the two most
recently completed calendar quarters prior to March 31, 2022 to $2,512.9 million
as of the end of the two most recently completed calendar quarters prior to
March 31, 2023. For both the three months ended March 31, 2023 and 2022, the
Base Management Fee rate was 1.250%.

Incentive Fee



Under the New Barings BDC Advisory Agreement, we pay Barings an incentive fee. A
portion of the incentive fee is based on our income and a portion is based on
our capital gains. The income-based fee will be determined and paid quarterly in
arrears based on the amount by which (x) the aggregate pre-incentive fee net
investment income in respect of the current calendar quarter and the eleven
preceding calendar quarters beginning with the calendar quarter that commences
on or after January 1, 2021, as the case may be (or the appropriate portion
thereof in the case of any of our first eleven calendar quarters that commences
on or after January 1, 2021) exceeds (y) the hurdle amount as calculated for the
same period. See Note 2 to our Unaudited Consolidated Financial Statements for
additional information regarding the terms of the New Barings BDC Advisory
Agreement and the fee arrangements thereunder. For the three months ended
March 31, 2023, the amount of income-based fee incurred was $9.6 million, as
compared to $4.8 million for the three months ended March 31, 2022. The increase
in the incentive fee for the three months ended March 31, 2023, as compared to
the three months ended March 31, 2022, relates predominately to an increase in
pre-incentive fee net investment income. The amount of pre-incentive fee net
investment income was $37.3 million as of March 31, 2023, as compared to $23.8
million as of March 31, 2022.
                                      119
--------------------------------------------------------------------------------

General and Administrative Expenses



We entered into the Administration Agreement with Barings in August 2018. Under
the terms of the Administration Agreement, Barings performs (or oversees, or
arranges for, the performance of) the administrative services necessary for our
operations. We reimburse Barings for the costs and expenses incurred by it in
performing its obligations and providing personnel and facilities under the
Administration Agreement in an amount to be negotiated and mutually agreed to by
us and Barings quarterly in arrears; provided that the agreed-upon quarterly
expense amount will not exceed the amount of expenses that would otherwise be
reimbursable by us under the Administration Agreement for the applicable
quarterly period, and Barings will not be entitled to the recoupment of any
amounts in excess of the agreed-upon quarterly expense amount. See Note 2 to our
Unaudited Consolidated Financial Statements for additional information regarding
the Administration Agreement. For the three months ended March 31, 2023, the
amount of administration expense incurred and invoiced by Barings for expenses
was approximately $0.7 million. For the three months ended March 31, 2022, the
amount of administration expense incurred and invoiced by Barings for expenses
was approximately $1.0 million. In addition to expenses incurred under the
Administration Agreement, general and administrative expenses include fees
payable to the members of our board of directors (the "Board") for their service
on the Board, D&O insurance costs, as well as legal and accounting expenses.

Net Realized Gains (Losses)



Net realized gains (losses) during the three months ended March 31, 2023 and
2022 were as follows:
                                                    Three Months       Three Months
                                                        Ended              Ended
                                                      March 31,          March 31,
      ($ in thousands)                                  2023               2022


      Net realized gain (losses):
      Non-Control / Non-Affiliate investments      $         771      $        (250)
      Affiliate investments                                    -                101

      Net realized gains (losses) on investments             771               (149)

      Foreign currency transactions                      (10,517)          

(1,293)


      Net realized gains (losses)                  $      (9,746)     $    

(1,442)




During the three months ended March 31, 2023, we recognized net realized losses
totaling $9.7 million, which consisted primarily of a net loss on foreign
currency transactions of $10.5 million, partially offset by a net gain on our
investment portfolio of $0.8 million. During the three months ended March 31,
2022, we recognized net realized losses totaling $1.4 million, which consisted
primarily of a net loss on foreign currency transactions of $1.3 million.

Net Unrealized Appreciation (Depreciation)

Net unrealized appreciation (depreciation) during the three months ended March 31, 2023 and 2022 was as follows:


                                                                         Three Months           Three Months
                                                                            Ended                  Ended
                                                                          March 31,              March 31,
($ in thousands)                                                             2023                   2022

Net unrealized appreciation (depreciation):
Non-Control / Non-Affiliate investments                                $       7,437          $     (28,587)
Affiliate investments                                                         10,841                 12,996
Control investments                                                           (7,269)                14,644
Net unrealized appreciation (depreciation) on investments                     11,009                   (947)
Credit support agreements                                                      5,586                   (400)
Foreign currency transactions                                                  5,375                  4,812
Net unrealized appreciation (depreciation)                             $    

21,970 $ 3,465




During the three months ended March 31, 2023, we recorded net unrealized
appreciation totaling $22.0 million, consisting of net unrealized appreciation
on our current portfolio of $11.8 million, unrealized appreciation of $0.9
million on the MVC credit support agreement with Barings, unrealized
appreciation of $4.7 million on the Sierra credit support agreement with
Barings, net unrealized appreciation related to foreign currency transactions of
$5.4 million, net of unrealized depreciation reclassification adjustments of
$0.7 million related to the net realized gains on the sales / repayments of
certain investments and $0.1 million of deferred taxes. The net unrealized
appreciation on our current portfolio of $11.8 million was driven primarily by
broad market moves for investments of $4.0 million, credit or fundamental
performance of investments of $0.9 million and the impact of foreign currency
exchange rates on investments of $6.9 million.
                                      120
--------------------------------------------------------------------------------


During the three months ended March 31, 2022, we recorded net unrealized
appreciation totaling $3.5 million, consisting of net unrealized appreciation on
our current portfolio of $0.1 million and net unrealized appreciation related to
foreign currency transactions of $4.8 million, net of unrealized depreciation of
$0.4 million on the MVC credit support agreement with Barings and net unrealized
depreciation reclassification adjustments of $1.0 million related to the
realized gains on the sales/ repayments of certain investments. The net
unrealized appreciation on our current portfolio of $0.1 million was driven
primarily by credit or fundamental performance of investments of $27.8 million,
partially offset by the impact of foreign currency exchange rates on investments
of $4.7 million and broad market moves for investments of $23.1 million.

Liquidity and Capital Resources



We believe that our current cash and foreign currencies on hand, our available
borrowing capacity under the February 2019 Credit Facility and our anticipated
cash flows from operations will be adequate to meet our cash needs for our daily
operations for at least the next twelve months. This "Liquidity and Capital
Resources" section should be read in conjunction with the notes to our Unaudited
Consolidated Financial Statements.

Cash Flows



For the three months ended March 31, 2023, we experienced a net decrease in cash
in the amount of $84.0 million. During that period, our operating activities
used $92.0 million in cash, consisting primarily of purchases of portfolio
investments of $179.6 million partially offset by proceeds from sales or
repayments of portfolio investments totaling $69.5 million. In addition, our
financing activities provided net cash of $8.0 million, consisting of net
borrowings under the February 2019 Credit Facility (as defined below under
"Financing Transactions") of $35.0 million, partially offset by dividends paid
in the amount of $27.0 million. As of March 31, 2023, we had $55.4 million of
cash and foreign currencies on hand.

For the three months ended March 31, 2022, we experienced a net increase in cash
in the amount of $70.2 million. During that period, our operating activities
used $18.8 million in cash, consisting primarily of purchases of portfolio
investments of $335.5 million, partially offset by net cash acquired from the
acquisition of Sierra of $101.9 million and proceeds from sales or repayments of
portfolio investments totaling $210.5 million. In addition, our financing
activities provided net cash of $89.0 million, consisting of net borrowings
under the February 2019 Credit Facility (as defined below under "Financing
Transactions") of $107.7 million, partially offset by dividends paid in the
amount of $15.0 million and share repurchases of $2.1 million. As of March 31,
2022, we had $154.4 million of cash and foreign currencies on hand.

Financing Transactions

February 2019 Credit Facility



On February 21, 2019, we entered into a senior secured credit facility with ING
Capital LLC ("ING"), as administrative agent, and the lenders party thereto (as
amended, restated and otherwise modified from time to time, the "February 2019
Credit Facility"). The initial commitments under the February 2019 Credit
Facility total $800.0 million. Effective on November 4, 2021, we increased
aggregate commitments under the February 2019 Credit Facility to $875.0 million
from $800.0 million pursuant to the accordion feature under the February 2019
Credit Facility, which allows for an increase in the total commitments to an
aggregate of $1.2 billion subject to certain conditions and the satisfaction of
specified financial covenants (the "February 2022 Amendment"). Effective on
February 25, 2022, we increased aggregate commitments under the February 2019
Credit Facility to $965.0 million from $875.0 million pursuant to the accordion
feature under the February 2019 Credit Facility, and the allowance for an
increase in the total commitments increased to $1.5 billion from $1.2 billion
subject to certain conditions and the satisfaction of specified financial
covenants. Effective on April 1, 2022, we increased the aggregate commitments
under the February 2019 Credit Facility to $1.1 billion from $965.0 million
pursuant to the accordion feature under the February 2019 Credit Facility, which
allows for an increase in the total commitments to an aggregate of $1.5 billion
subject to certain conditions and the satisfaction of specified financial
covenants. We can borrow foreign currencies directly under the February 2019
Credit Facility (the "April 2022 Amendment"). The February 2019 Credit Facility,
which is structured as a revolving credit facility, is secured primarily by a
material portion of our assets and guaranteed by certain of our subsidiaries.
Following the termination on June 30, 2020 of Barings BDC Senior Funding I,
LLC's ("BSF") credit facility entered into in August 2018 with Bank of America,
N.A. (the "August 2018 Credit Facility"), BSF became a subsidiary guarantor and
its assets secure the February 2019 Credit Facility. The revolving period of the
February 2019 Credit Facility ends on February 21, 2024, followed by a one-year
repayment period with a maturity date of February 21, 2025.

Borrowings denominated in U.S. Dollars under the February 2019 Credit Facility
bear interest, subject to our election, on a per annum basis equal to (i) the
alternate base rate plus 1.25% (or 1.00% for so long as we maintain an
investment grade credit rating) or (ii) the term Secured Overnight Financing
Rate ("SOFR") plus 2.25% (or 2.00% for so long as we maintain an investment
grade credit rating) plus a credit spread adjustment of 0.10% for borrowings
with an interest period of one month, 0.15% for borrowings with an interest
period of three months or 0.25% for borrowings with an interest period of six
months.
                                      121
--------------------------------------------------------------------------------


For borrowings denominated in certain foreign currencies other than Australian
dollars, the applicable currency rate for the foreign currency as defined in the
credit agreement plus 2.00% (or 2.25% if we no longer maintain an investment
grade credit rating) or for borrowings denominated in Australian dollars, the
applicable Australian dollars Screen Rate, plus 2.20% (or 2.45% if we no longer
maintain an investment grade credit rating). The alternate base rate is equal to
the greatest of (i) the prime rate, (ii) the federal funds rate plus 0.5%, (iii)
the Overnight Bank Funding Rate plus 0.5%, (iv) one-month term SOFR plus 1.0%
plus a credit spread adjustment of 0.10% and (v) 1.0%.

In addition, we pay a commitment fee of (i) 0.5% per annum on undrawn amounts if
the unused portion of the February 2019 Credit Facility is greater than
two-thirds of total commitments or (ii) 0.375% per annum on undrawn amounts if
the unused portion of the February 2019 Credit Facility is equal to or less than
two-thirds of total commitments. In connection with entering into the February
2019 Credit Facility, we incurred financing fees of approximately $6.4 million,
which will be amortized over the life of the February 2019 Credit Facility. In
connection with the February 2022 Amendment and the April 2022 Amendment, we
incurred financing fees of approximately $1.7 million, which will be amortized
over the remaining life of the February 2019 Credit Facility.

As of March 31, 2023, we were in compliance with all covenants under the
February 2019 Credit Facility and had U.S. dollar borrowings of $532.5 million
outstanding under the February 2019 Credit Facility with an interest rate of
6.798% (one month SOFR of 4.698%), borrowings denominated in Swedish krona of
12.8kr million ($1.2 million U.S. dollars) with an interest rate of 5.000% (one
month STIBOR of 3.000%), borrowings denominated in British pounds sterling of
£68.6 million ($84.8 million U.S. dollars) with an interest rate of 5.960% (one
month SONIA of 3.960%) and borrowings denominated in Euros of €138.6 million
($150.6 million U.S. dollars) with an interest rate of 4.625% (one month EURIBOR
of 2.625%). The borrowings denominated in foreign currencies were translated
into U.S. dollars based on the spot rate at the relevant balance sheet date. The
impact resulting from changes in foreign exchange rates on the February 2019
Credit Facility borrowings is included in "Net unrealized appreciation
(depreciation) - foreign currency transactions" in our Unaudited Consolidated
Statements of Operations.

The fair values of the borrowings outstanding under the February 2019 Credit
Facility are based on a market yield approach and current interest rates, which
are Level 3 inputs to the market yield model. As of March 31, 2023, the total
fair value of the borrowings outstanding under the February 2019 Credit Facility
was $769.1 million. See Note 5 to our Unaudited Consolidated Financial
Statements for additional information regarding the February 2019 Credit
Facility.

August 2025 Notes



On August 3, 2020, we entered into a Note Purchase Agreement (the "August 2020
NPA") with Massachusetts Mutual Life Insurance Company governing the issuance of
(1) $50.0 million in aggregate principal amount of Series A senior unsecured
notes due August 2025 (the "Series A Notes due 2025") with a fixed interest rate
of 4.66% per year, and (2) up to $50.0 million in aggregate principal amount of
additional senior unsecured notes due August 2025 with a fixed interest rate per
year to be determined (the "Additional Notes" and, collectively with the Series
A Notes due 2025, the "August 2025 Notes"), in each case, to qualified
institutional investors in a private placement. An aggregate principal amount of
$25.0 million of the Series A Notes due 2025 was issued on September 24, 2020
and an aggregate principal amount of $25.0 million of the Series A Notes due
2025 was issued on September 29, 2020, both of which will mature on August 4,
2025 unless redeemed, purchased or prepaid prior to such date by us in
accordance with their terms. Interest on the August 2025 Notes is due
semiannually in March and September, beginning in March 2021. In addition, we
are obligated to offer to repay the August 2025 Notes at par (plus accrued and
unpaid interest to, but not including, the date of prepayment) if certain change
in control events occur. Subject to the terms of the August 2020 NPA, we may
redeem the August 2025 Notes in whole or in part at any time or from time to
time at our option at par plus accrued interest to the prepayment date and, if
redeemed on or before November 3, 2024, a make-whole premium. The August 2025
Notes are guaranteed by certain of our subsidiaries, and are our general
unsecured obligations that rank pari passu with all outstanding and future
unsecured unsubordinated indebtedness issued by us.

The Company's permitted issuance period for the Additional Notes under the August 2020 NPA expired on February 3, 2022, prior to which date the Company issued no Additional Notes.



The August 2020 NPA contains certain representations and warranties, and various
covenants and reporting requirements customary for senior unsecured notes issued
in a private placement, including, without limitation, affirmative and negative
covenants such as information reporting, maintenance of our status as a BDC
within the meaning of the 1940 Act, certain restrictions with respect to
transactions with affiliates, fundamental changes, changes of line of business,
permitted liens, investments and restricted payments, minimum shareholders'
equity, maximum net debt to equity ratio and minimum asset coverage ratio. The
August 2020 NPA also contains customary events of default with customary cure
and notice periods, including, without limitation, nonpayment, incorrect
representation in any material respect, breach of covenant, cross-default under
our other indebtedness or that of our subsidiary guarantors, certain judgements
and orders, and certain events of
                                      122
--------------------------------------------------------------------------------


bankruptcy. Upon the occurrence of an event of default, the holders of at least
66-2/3% in principal amount of the August 2025 Notes at the time outstanding may
declare all August 2025 Notes then outstanding to be immediately due and
payable. As of March 31, 2023, we were in compliance with all covenants under
the August 2020 NPA.

The August 2025 Notes were offered in reliance on Section 4(a)(2) of the
Securities Act of 1933, as amended (the "Securities Act"). The August 2025 Notes
have not and will not be registered under the Securities Act or any state
securities laws and, unless so registered, may not be offered or sold in the
United States except pursuant to an exemption from, or in a transaction not
subject to, the registration requirements of the Securities Act, as applicable.

As of March 31, 2023, the fair value of the outstanding August 2025 Notes was
$46.6 million. The fair value determination of the August 2025 Notes was based
on a market yield approach and current interest rates, which are Level 3 inputs
to the market yield model.

November Notes

On November 4, 2020, we entered into a Note Purchase Agreement (the "November
2020 NPA") governing the issuance of (1) $62.5 million in aggregate principal
amount of Series B senior unsecured notes due November 2025 (the "Series B
Notes") with a fixed interest rate of 4.25% per year and (2) $112.5 million in
aggregate principal amount of Series C senior unsecured notes due November 2027
(the "Series C Notes," and, collectively with the Series B Notes, the "November
Notes") with a fixed interest rate of 4.75% per year, in each case, to qualified
institutional investors in a private placement. Each stated interest rate is
subject to a step up of (x) 0.75% per year, to the extent the applicable
November Notes do not satisfy certain investment grade conditions and/or (y)
1.50% per year, to the extent the ratio of our secured debt to total assets
exceeds specified thresholds, measured as of each fiscal quarter end. The
November Notes were delivered and paid for on November 5, 2020.

The Series B Notes will mature on November 4, 2025, and the Series C Notes will
mature on November 4, 2027 unless redeemed, purchased or prepaid prior to such
date by us in accordance with their terms. Interest on the November Notes is due
semiannually in May and November, beginning in May 2021. In addition, we are
obligated to offer to repay the November Notes at par (plus accrued and unpaid
interest to, but not including, the date of prepayment) if certain change in
control events occur. Subject to the terms of the November 2020 NPA, we may
redeem the Series B Notes and the Series C Notes in whole or in part at any time
or from time to time at our option at par plus accrued interest to the
prepayment date and, if redeemed on or before May 4, 2025, with respect to the
Series B Notes, or on or before May 4, 2027, with respect to the Series C Notes,
a make-whole premium. The November Notes are guaranteed by certain of our
subsidiaries, and are our general unsecured obligations that rank pari passu
with all outstanding and future unsecured unsubordinated indebtedness issued by
us.

The November 2020 NPA contains certain representations and warranties, and
various covenants and reporting requirements customary for senior unsecured
notes issued in a private placement, including, without limitation, affirmative
and negative covenants such as information reporting, maintenance of our status
as a BDC within the meaning of the 1940 Act, certain restrictions with respect
to transactions with affiliates, fundamental changes, changes of line of
business, permitted liens, investments and restricted payments, minimum
shareholders' equity, maximum net debt to equity ratio and minimum asset
coverage ratio. The November 2020 NPA also contains customary events of default
with customary cure and notice periods, including, without limitation,
nonpayment, incorrect representation in any material respect, breach of
covenant, cross-default under our other indebtedness or that of our subsidiary
guarantors, certain judgements and orders, and certain events of bankruptcy.
Upon the occurrence of an event of default, the holders of at least 66-2/3% in
principal amount of the November Notes at the time outstanding may declare all
November Notes then outstanding to be immediately due and payable. As of
March 31, 2023, we were in compliance with all covenants under the November 2020
NPA.

The November Notes were offered in reliance on Section 4(a)(2) of the Securities
Act. The November Notes have not and will not be registered under the Securities
Act or any state securities laws and, unless so registered, may not be offered
or sold in the United States except pursuant to an exemption from, or in a
transaction not subject to, the registration requirements of the Securities Act,
as applicable.

As of March 31, 2023, the fair value of the outstanding Series B Notes and the
Series C Notes was $56.8 million and $98.3 million, respectively. The fair value
determinations of the Series B Notes and Series C Notes were based on a market
yield approach and current interest rates, which are Level 3 inputs to the
market yield model.

February Notes



On February 25, 2021, we entered into a Note Purchase Agreement (the "February
2021 NPA") governing the issuance of (1) $80.0 million in aggregate principal
amount of Series D senior unsecured notes due February 26, 2026 (the "Series D
                                      123
--------------------------------------------------------------------------------


Notes") with a fixed interest rate of 3.41% per year and (2) $70.0 million in
aggregate principal amount of Series E senior unsecured notes due February 26,
2028 (the "Series E Notes" and, collectively with the Series D Notes, the
"February Notes") with a fixed interest rate of 4.06% per year, in each case, to
qualified institutional investors in a private placement. Each stated interest
rate is subject to a step up of (x) 0.75% per year, to the extent the applicable
February Notes do not satisfy certain investment grade rating conditions and/or
(y) 1.50% per year, to the extent the ratio of our secured debt to total assets
exceeds specified thresholds, measured as of each fiscal quarter end. The
February Notes were delivered and paid for on February 26, 2021.

The Series D Notes will mature on February 26, 2026, and the Series E Notes will
mature on February 26, 2028 unless redeemed, purchased or prepaid prior to such
date by us in accordance with the terms of the February 2021 NPA. Interest on
the February Notes is due semiannually in February and August of each year,
beginning in August 2021. In addition, we are obligated to offer to repay the
February Notes at par (plus accrued and unpaid interest to, but not including,
the date of prepayment) if certain change in control events occur. Subject to
the terms of the February 2021 NPA, we may redeem the Series D Notes and the
Series E Notes in whole or in part at any time or from time to time at our
option at par plus accrued interest to the prepayment date and, if redeemed on
or before August 26, 2025, with respect to the Series D Notes, or on or before
August 26, 2027, with respect to the Series E Notes, a make-whole premium. The
February Notes are guaranteed by certain of our subsidiaries, and are our
general unsecured obligations that rank pari passu with all outstanding and
future unsecured unsubordinated indebtedness issued by us.

The February 2021 NPA contains certain representations and warranties, and
various covenants and reporting requirements customary for senior unsecured
notes issued in a private placement, including, without limitation, information
reporting, maintenance of our status as a BDC within the meaning of the 1940
Act, and certain restrictions with respect to transactions with affiliates,
fundamental changes, changes of line of business, permitted liens, investments
and restricted payments. In addition, the February 2021 NPA contains the
following financial covenants: (a) maintaining a minimum obligors' net worth,
measured as of each fiscal quarter end; (b) not permitting our asset coverage
ratio, as of the date of the incurrence of any debt for borrowed money or the
making of any cash dividend to shareholders, to be less than the statutory
minimum then applicable to us under the 1940 Act; and (c) not permitting our net
debt to equity ratio to exceed 2.0x, measured as of each fiscal quarter end.

The February 2021 NPA also contains customary events of default with customary
cure and notice periods, including, without limitation, nonpayment, incorrect
representation in any material respect, breach of covenant, cross-default under
other indebtedness or that of our subsidiary guarantors, certain judgements and
orders, and certain events of bankruptcy. Upon the occurrence of certain events
of default, the holders of at least 66-2/3% in principal amount of the February
Notes at the time outstanding may declare all February Notes then outstanding to
be immediately due and payable. As of March 31, 2023, we were in compliance with
all covenants under the February 2021 NPA.

The February Notes were offered in reliance on Section 4(a)(2) of the Securities
Act. The February Notes have not and will not be registered under the Securities
Act or any state securities laws and, unless so registered, may not be offered
or sold in the United States except pursuant to an exemption from, or in a
transaction not subject to, the registration requirements of the Securities Act,
as applicable.

As of March 31, 2023, the fair value of the outstanding Series D Notes and the
Series E Notes was $70.9 million and $59.1 million, respectively. The fair value
determinations of the Series D Notes and Series E Notes were based on a market
yield approach and current interest rates, which are Level 3 inputs to the
market yield model.

November 2026 Notes



On November 23, 2021, we entered into an Indenture (the "Base Indenture") and a
Supplemental Indenture (the "First Supplemental Indenture" and, together with
the Base Indenture, the "Indenture") with U.S. Bank National Association (the
"Trustee"). The First Supplemental Indenture relates to our issuance of $350.0
million aggregate principal amount of its 3.300% notes due 2026 (the "November
2026 Notes").

The November 2026 Notes will mature on November 23, 2026 and may be redeemed in
whole or in part at our option at any time or from time to time at the
redemption prices set forth in the Indenture. The November 2026 Notes bear
interest at a rate of 3.300% per year payable semi-annually on May 23 and
November 23 of each year, commencing on May 23, 2022. The November 2026 Notes
are our general unsecured obligations that rank senior in right of payment to
all of our existing and future indebtedness that is expressly subordinated in
right of payment to the November 2026 Notes, rank pari passu with all existing
and future unsecured unsubordinated indebtedness issued by us, rank effectively
junior to any of our secured indebtedness (including unsecured indebtedness that
we later secure) to the extent of the value of the assets securing such
                                      124
--------------------------------------------------------------------------------

indebtedness, and rank structurally junior to all existing and future indebtedness (including trade payables) incurred by our subsidiaries, financing vehicles or similar facilities.



The Indenture contains certain covenants, including covenants requiring us to
comply with the asset coverage requirements of Section 18(a)(1)(A) as modified
by Sections 61(a)(1) and (2) of the 1940 Act, whether or not we are subject to
those requirements, and to provide financial information to the holders of the
November 2026 Notes and the Trustee if we are no longer subject to the reporting
requirements under the Exchange Act. These covenants are subject to important
limitations and exceptions that are described in the Indenture.

In addition, on the occurrence of a "change of control repurchase event," as
defined in the Indenture, we will generally be required to make an offer to
purchase the outstanding November 2026 Notes at a price equal to 100% of the
principal amount of such November 2026 Notes plus accrued and unpaid interest to
the repurchase date.

The November 2026 Notes were offered to qualified institutional buyers pursuant
to Rule 144A under the Securities Act and to certain non-U.S. persons outside
the United States pursuant to Regulation S under the Securities Act. Concurrent
with the closing of November 2026 Notes offering, we entered into a registration
rights agreement for the benefit of the purchasers of the November 2026 Notes.
Pursuant to the terms of this registration rights agreement, we filed a
registration statement on Form N-14 with the SEC, which was subsequently
declared effective, to permit electing holders of the November 2026 Notes to
exchange all of their outstanding restricted November 2026 Notes for an equal
aggregate principal amount of new November 2026 Notes (the "Exchange Notes").
The Exchange Notes have terms substantially identical to the terms of the
November 2026 Notes, except that the Exchange Notes are registered under the
Securities Act, and certain transfer restrictions, registration rights, and
additional interest provisions relating to the November 2026 Notes do not apply
to the Exchange Notes.

As of March 31, 2023, the fair value of the outstanding November 2026 Notes was
$296.5 million. The fair value determinations of the November 2026 Notes were
based on a market yield approach and current interest rates, which are Level 3
inputs to the market yield model.

Share Repurchase Program



In connection with the closing of the MVC Acquisition on December 23, 2020, we
committed to make open-market purchases of shares of our common stock in an
aggregate amount of up to $15.0 million at then-current market prices at any
time shares trade below 90% of our then most recently disclosed NAV per share.
Any repurchases pursuant to the authorized program occurred during the 12-month
period that commenced upon the filing of our quarterly report on Form 10-Q for
the quarter ended March 31, 2021, which occurred on May 6, 2021, and were made
in accordance with applicable legal, contractual and regulatory requirements.
The MVC-related repurchase program terminated on May 6, 2022. Prior to its
termination, we repurchased a total of 207,677 shares of common stock in the
open market under the MVC repurchase program at an average price of $10.14 per
share, including broker commissions.

In connection with the completion of the acquisition of Sierra, we committed to
make open-market purchases of shares of our common stock in an aggregate amount
of up to $30.0 million at then-current market prices at any time shares trade
below 90% of our then most recently disclosed NAV per share. Any repurchases
pursuant to the authorized program occurred during the 12-month period
commencing on April 1, 2022 and were made in accordance with a Rule 10b5-1
purchase plan that qualifies for the safe harbors provided by Rules 10b5-1 and
10b-18 under the Exchange Act, as well as subject to compliance with our
covenant and regulatory requirements. During the year ended December 31, 2022,
we repurchased the maximum amount of $30.0 million of common stock authorized
under the Sierra share repurchase program. In total under the Sierra share
repurchase program, we repurchased a total of 3,179,168 shares of common stock
in the open market under the authorized program at an average price of $9.44 per
share, including broker commissions.

On February 23, 2023, our Board authorized a new 12-month share repurchase
program. Under the program, we may repurchase, during the 12-month period
commencing on March 1, 2023, up to $30.0 million in the aggregate of our
outstanding common stock in the open market at prices below the then-current NAV
per share. The timing, manner, price and amount of any share repurchases will be
determined by us, at our discretion, based upon the evaluation of economic and
market conditions, our stock price, applicable legal, contractual and regulatory
requirements and other factors. The program is expected to be in effect until
March 1, 2024, unless extended or until the aggregate repurchase amount that has
been approved by our Board has been expended. The program does not require us to
repurchase any specific number of shares, and we cannot assure stockholders that
any shares will be repurchased under the program. The program may be suspended,
extended, modified or discontinued at any time. During the three months ended
March 31, 2023, we did not repurchase any shares.
                                      125
--------------------------------------------------------------------------------

Distributions to Stockholders



We intend to pay quarterly distributions to our stockholders out of assets
legally available for distribution. We have adopted a dividend reinvestment plan
("DRIP") that provides for reinvestment of dividends on behalf of our
stockholders, unless a stockholder elects to receive cash. As a result, when we
declare a dividend, stockholders who have not opted out of the DRIP will have
their dividends automatically reinvested in shares of our common stock, rather
than receiving cash dividends.

We have elected to be treated as a RIC under the Code, and intend to make the
required distributions to our stockholders as specified therein. In order to
maintain our tax treatment as a RIC and to obtain RIC tax benefits, we must meet
certain minimum distribution, source-of-income and asset diversification
requirements. If such requirements are met, then we are generally required to
pay income taxes only on the portion of our taxable income and gains we do not
distribute (actually or constructively) and certain built-in gains. We have
historically met our minimum distribution requirements and continually monitor
our distribution requirements with the goal of ensuring compliance with the
Code. We can offer no assurance that we will achieve results that will permit
the payment of any level of cash distributions and our ability to make
distributions will be limited by the asset coverage requirement and related
provisions under the 1940 Act and contained in any applicable indenture or
financing agreement and related supplements. In addition, in order to satisfy
the annual distribution requirement applicable to RICs, we may declare a
significant portion of our dividends in shares of our common stock instead of in
cash. As long as a portion of such dividend is paid in cash (which portion may
be as low as 20% of such dividend under published guidance from the Internal
Revenue Service) and certain requirements are met, the entire distribution will
be treated as a dividend for U.S. federal income tax purposes. As a result, a
stockholder generally would be subject to tax on 100% of the fair market value
of the dividend on the date the dividend is received by the stockholder in the
same manner as a cash dividend, even though most of the dividend was paid in
shares of our common stock.

The minimum distribution requirements applicable to RICs require us to
distribute to our stockholders each year at least 90% of our investment company
taxable income, or ICTI, as defined by the Code. Depending on the level of ICTI
and net capital gain, if any, earned in a tax year, we may choose to carry
forward ICTI in excess of current year distributions into the next tax year and
pay a 4% U.S. federal excise tax on such excess. Any such carryover ICTI must be
distributed before the end of the next tax year through a dividend declared
prior to filing the final tax return related to the year which generated such
ICTI.

ICTI generally differs from net investment income for financial reporting
purposes due to temporary and permanent differences in the recognition of income
and expenses. We may be required to recognize ICTI in certain circumstances in
which we do not receive cash. For example, if we hold debt obligations that are
treated under applicable tax rules as having original issue discount (such as
debt instruments issued with warrants), we must include in ICTI each year a
portion of the original issue discount that accrues over the life of the
obligation, regardless of whether cash representing such income is received by
us in the same taxable year. We may also have to include in ICTI other amounts
that we have not yet received in cash, such as (i) PIK interest income and (ii)
interest income from investments that have been classified as non-accrual for
financial reporting purposes. Interest income on non-accrual investments is not
recognized for financial reporting purposes, but generally is recognized in
ICTI. Because any original issue discount or other amounts accrued will be
included in our ICTI for the year of accrual, we may be required to make a
distribution to our stockholders in order to satisfy the minimum distribution
requirements, even though we will not have received and may not ever receive any
corresponding cash amount. ICTI also excludes net unrealized appreciation or
depreciation, as investment gains or losses are not included in taxable income
until they are realized.

Recent Developments

Subsequent to March 31, 2023, we made approximately $2.7 million of new commitments, of which $2.2 million closed and funded. The $2.2 million of investments consists of $1.9 million of first lien senior secured debt investments and $0.3 million of subordinated debt investments. The weighted average yield of the debt investments was 11.2%. In addition, we funded $15.5 million of previously committed debt and equity facilities.

On May 4, 2023, the Board declared a quarterly distribution of $0.25 per share payable on June 14, 2023 to holders of record as of June 7, 2023.

Critical Accounting Policies and Use of Estimates



The preparation of our unaudited financial statements in accordance with U.S.
GAAP requires management to make certain estimates and assumptions that affect
the reported amounts of assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses for the periods
covered by such financial statements. We have identified investment valuation
and revenue recognition as our most critical accounting estimates. On an ongoing
basis, we evaluate our estimates, including those related to the matters
described below. These estimates are based on the information that is currently
available to us and on various other assumptions that we believe to be
reasonable under the circumstances. Actual results could
                                      126
--------------------------------------------------------------------------------

differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

Valuation of Investments



The Adviser conducts the valuation of our investments, upon which our net asset
value is primarily based, in accordance with its valuation policy, as well as
established and documented processes and methodologies for determining the fair
values of portfolio company investments on a recurring (at least quarterly)
basis in accordance with the 1940 Act and FASB ASC Topic 820, Fair Value
Measurements and Disclosures ("ASC Topic 820"). Our current valuation policy and
processes were established by the Adviser and were approved by the Board.

As of March 31, 2023, our investment portfolio, valued at fair value in
accordance with the Board-approved valuation policies, represented approximately
212% of our total net assets, as compared to approximately 205% of our total net
assets as of December 31, 2022.

Under ASC Topic 820, fair value is the price that would be received to sell an
asset or paid to transfer a liability in an orderly transaction between a
willing buyer and a willing seller at the measurement date. For our portfolio
securities, fair value is generally the amount that we might reasonably expect
to receive upon the current sale of the security. The fair value measurement
assumes that the sale occurs in the principal market for the security, or in the
absence of a principal market, in the most advantageous market for the security.
If no market for the security exists or if we do not have access to the
principal market, the security should be valued based on the sale occurring in a
hypothetical market.

Under ASC Topic 820, there are three levels of valuation inputs, as follows:

Level 1 Inputs - include quoted prices (unadjusted) in active markets for identical assets or liabilities.



Level 2 Inputs - include quoted prices for similar assets and liabilities in
active markets, and inputs that are observable for the asset or liability,
either directly or indirectly, for substantially the full term of the financial
instrument.

Level 3 Inputs - include inputs that are unobservable and significant to the fair value measurement.



A financial instrument is categorized within the ASC Topic 820 valuation
hierarchy based upon the lowest level of input to the valuation process that is
significant to the fair value measurement. For example, a Level 3 fair value
measurement may include inputs that are observable (Levels 1 and 2) and
unobservable (Level 3). Therefore, unrealized appreciation and depreciation
related to such investments categorized as Level 3 investments within the tables
in the notes to our consolidated financial statements may include changes in
fair value that are attributable to both observable inputs (Levels 1 and 2) and
unobservable inputs (Level 3).

Our investment portfolio includes certain debt and equity instruments of
privately held companies for which quoted prices or other observable inputs
falling within the categories of Level 1 and Level 2 are generally not
available. In such cases, the Adviser determines the fair value of our
investments in good faith primarily using Level 3 inputs. In certain cases,
quoted prices or other observable inputs exist, and if so, the Adviser assesses
the appropriateness of the use of these third-party quotes in determining fair
value based on (i) its understanding of the level of actual transactions used by
the broker to develop the quote and whether the quote was an indicative price or
binding offer and (ii) the depth and consistency of broker quotes and the
correlation of changes in broker quotes with underlying performance of the
portfolio company.

There is no single standard for determining fair value in good faith, as fair
value depends upon the specific circumstances of each individual investment. The
recorded fair values of our Level 3 investments may differ significantly from
fair values that would have been used had an active market for the securities
existed. In addition, changes in the market environment and other events that
may occur over the life of the investments may cause the gains or losses
ultimately realized on these investments to be different than the valuations
currently assigned.

Investment Valuation Process



The Board must determine fair value in good faith for any or all of our
investments for which market quotations are not readily available. The Board has
designated the Adviser as valuation designee to perform the fair value
determinations relating to the value of these assets. Barings has established a
pricing committee that is, subject to the oversight of the Board, responsible
for the approval, implementation and oversight of the processes and
methodologies that relate to the pricing and valuation of assets we hold.
Barings uses independent third-party providers to price the portfolio, but in
the event an acceptable price cannot be obtained from an approved external
source, Barings will utilize alternative methods in accordance with internal
pricing procedures established by Barings' pricing committee.
                                      127
--------------------------------------------------------------------------------


At least annually, Barings conducts reviews of the primary pricing vendors to
validate that the inputs used in the vendors' pricing process are deemed to be
market observable. While Barings is not provided access to proprietary models of
the vendors, the reviews have included on-site walkthroughs of the pricing
process, methodologies and control procedures for each asset class and level for
which prices are provided. The review also includes an examination of the
underlying inputs and assumptions for a sample of individual securities across
asset classes, credit rating levels and various durations, a process Barings
continues to perform annually. In addition, the pricing vendors have an
established challenge process in place for all security valuations, which
facilitates identification and resolution of prices that fall outside expected
ranges. Barings believes that the prices received from the pricing vendors are
representative of prices that would be received to sell the assets at the
measurement date (i.e., exit prices).

Our money market fund investments are generally valued using Level 1 inputs and
our equity investments listed on an exchange or on the NASDAQ National Market
System are valued using Level 1 inputs, using the last quoted sale price of that
day. Our syndicated senior secured loans and structured product investments are
generally valued using Level 2 inputs, which are generally valued at the bid
quotation obtained from dealers in loans by an independent pricing service. Our
middle-market, private debt and equity investments are generally valued using
Level 3 inputs.

Independent Valuation

The fair value of loans and equity investments that are not syndicated or for
which market quotations are not readily available, including middle-market
loans, are generally submitted to independent providers to perform an
independent valuation on those loans and equity investments as of the end of
each quarter. Such loans and equity investments are initially held at cost, as
that is a reasonable approximation of fair value on the acquisition date, and
monitored for material changes that could affect the valuation (for example,
changes in interest rates or the credit quality of the borrower). At the quarter
end following that of the initial acquisition, such loans and equity investments
are generally sent to a valuation provider which will determine the fair value
of each investment. The independent valuation providers apply various methods
(synthetic rating analysis, discounting cash flows, and re-underwriting
analysis) to establish the rate of return a market participant would require
(the "discount rate") as of the valuation date, given market conditions,
prevailing lending standards and the perceived credit quality of the issuer.
Future expected cash flows for each investment are discounted back to present
value using these discount rates in the discounted cash flow analysis. A range
of values will be provided by the valuation provider and Barings will determine
the point within that range that it will use. If the Barings pricing committee
disagrees with the price range provided, it may make a fair value recommendation
to Barings that is outside of the range provided by the independent valuation
provider and the reasons therefore. In certain instances, we may determine that
it is not cost-effective, and as a result is not in the stockholders' best
interests, to request an independent valuation firm to perform an independent
valuation on certain investments. Such instances include, but are not limited
to, situations where the fair value of the investment in the portfolio company
is determined to be insignificant relative to the total investment portfolio.

Valuation Inputs



The Adviser's valuation techniques are based upon both observable and
unobservable pricing inputs. Observable inputs reflect market data obtained from
independent sources, while unobservable inputs reflect the Adviser's market
assumptions. The Adviser's assessment of the significance of a particular input
to the fair value measurement in its entirety requires judgment and considers
factors specific to the financial instrument. An independent pricing service
provider is the preferred source of pricing a loan, however, to the extent the
independent pricing service provider price is unavailable or not relevant and
reliable, the Adviser will utilize alternative approaches such as broker quotes
or manual prices. The Adviser attempts to maximize the use of observable inputs
and minimize the use of unobservable inputs. The availability of observable
inputs can vary from investment to investment and is affected by a wide variety
of factors, including the type of security, whether the security is new and not
yet established in the marketplace, the liquidity of markets and other
characteristics particular to the security.

Valuation of Investments in Jocassee, Thompson Rivers, Waccamaw River, Sierra JV and MVC Private Equity Fund LP



As Jocassee, Thompson Rivers, Waccamaw River, Sierra JV and MVC Private Equity
Fund LP are investment companies with no readily determinable fair values, the
Adviser estimates the fair value of our investments in these entities using net
asset value of each company and our ownership percentage as a practical
expedient. The net asset value is determined in accordance with the specialized
accounting guidance for investment companies.
                                      128
--------------------------------------------------------------------------------



Revenue Recognition

Interest and Dividend Income

Interest income, including amortization of premium and accretion of discount, is
recorded on the accrual basis to the extent that such amounts are expected to be
collected. Generally, when interest and/or principal payments on a loan become
past due, or if we otherwise do not expect the borrower to be able to service
its debt and other obligations, we will place the loan on non-accrual status and
will generally cease recognizing interest income on that loan for financial
reporting purposes until all principal and interest have been brought current
through payment or due to a restructuring such that the interest income is
deemed to be collectible. The cessation of recognition of such interest will
negatively impact the reported fair value of the investment. We write off any
previously accrued and uncollected interest when it is determined that interest
is no longer considered collectible.

Interest income from investments in the equity class of a collateralized loan
obligation ("CLO") security (typically subordinated notes) is recorded based
upon an estimation of an effective yield to expected maturity utilizing assumed
cash flows in accordance with ASC 325-40, Beneficial Interests in Securitized
Financial Assets. We monitor the expected cash flows from these investments,
including the expected residual payments, and the effective yield is determined
and updated periodically. Any difference between the cash distribution received
and the amount calculated pursuant to the effective interest method is recorded
as an adjustment to the cost basis of such investments.

Dividend income on preferred equity securities is recorded on the accrual basis
to the extent that such amounts are payable by the portfolio company and are
expected to be collected. Dividend income on common equity is recorded on the
ex-dividend date.

We may have to include interest income in our ICTI, including original issue
discount income, from investments that have been classified as non-accrual for
financial reporting purposes. Interest income on non-accrual investments is not
recognized for financial reporting purposes, but generally is recognized in
ICTI. As a result, we may be required to make a distribution to our stockholders
in order to satisfy the minimum distribution requirements to maintain our RIC
tax treatment, even though we will not have received and may not ever receive
any corresponding cash amount. Additionally, any loss recognized by us for U.S.
federal income tax purposes on previously accrued interest income will be
treated as a capital loss.

Fee Income



Origination, facility, commitment, consent and other advance fees received in
connection with the origination of a loan, or Loan Origination Fees, are
recorded as deferred income and recognized as investment income over the term of
the loan. Upon prepayment of a loan, any unamortized Loan Origination Fees are
recorded as investment income. In the general course of our business, we receive
certain fees from portfolio companies, which are non-recurring in nature. Such
fees include loan prepayment penalties, structuring fees, covenant waiver fees
and loan amendment fees, and are recorded as investment income when earned.

Fee income for the three months ended March 31, 2023 and 2022 was as follows:

                                                        Three Months        Three Months
                                                           Ended               Ended
($ in thousands)                                       March 31, 2023      March 31, 2022
Recurring Fee Income:
Amortization of loan origination fees                 $        1,672      $ 

1,327


Management, valuation and other fees                             593                (585)
Total Recurring Fee Income                                     2,265                 742
Non-Recurring Fee Income:

Acceleration of unamortized loan origination fees                345        

196


Advisory, loan amendment and other fees                          690        

259


Total Non-Recurring Fee Income                                 1,035                 455
Total Fee Income                                      $        3,300      $        1,197


                                      129

--------------------------------------------------------------------------------

Payment-in-Kind (PIK) Interest Income



We currently hold, and expect to hold in the future, some loans in our portfolio
that contain PIK interest provisions. PIK interest, computed at the contractual
rate specified in each loan agreement, is periodically added to the principal
balance of the loan, rather than being paid to us in cash, and is recorded as
interest income. Thus, the actual collection of PIK interest may be deferred
until the time of debt principal repayment.

PIK interest, which is a non-cash source of income at the time of recognition,
is included in our taxable income and therefore affects the amount we are
required to distribute to our stockholders to maintain our tax treatment as a
RIC for U.S. federal income tax purposes, even though we have not yet collected
the cash. Generally, when current cash interest and/or principal payments on a
loan become past due, or if we otherwise do not expect the borrower to be able
to service its debt and other obligations, we will place the loan on non-accrual
status and will generally cease recognizing PIK interest income on that loan for
financial reporting purposes until all principal and interest have been brought
current through payment or due to a restructuring such that the interest income
is deemed to be collectible. We write off any previously accrued and uncollected
PIK interest when it is determined that the PIK interest is no longer
collectible.

We may have to include in our ICTI, PIK interest income from investments that
have been classified as non-accrual for financial reporting purposes. Interest
income on non-accrual investments is not recognized for financial reporting
purposes, but generally is recognized in ICTI. As a result, we may be required
to make a distribution to our stockholders in order to satisfy the minimum
distribution requirements, even though we will not have received and may not
ever receive any corresponding cash amount.

Unused Commitments



In the normal course of business, we are party to financial instruments with
off-balance sheet risk, consisting primarily of unused commitments to extend
financing to our portfolio companies. Since commitments may expire without being
drawn upon, the total commitment amount does not necessarily represent future
cash requirements. As of March 31, 2023 and December 31, 2022, we believed that
we had adequate financial resources to satisfy our unfunded commitments. The
balances of unused commitments to extend financing as of March 31, 2023 and
December 31, 2022 were as follows:


Portfolio Company
($ in thousands)                              Investment Type                   March 31, 2023           December 31, 2022
Accurus Aerospace Corporation(1)(2)           Revolver                        $           922          $            1,152
AlliA Insurance Brokers NV(1)(2)(3)           Delayed Draw Term Loan                    2,055                           -
Amtech LLC(1)                                 Delayed Draw Term Loan                    1,527                       1,527
Amtech LLC(1)                                 Revolver                                    682                         545
AnalytiChem Holding GmbH(1)(2)(3)             Bridge Revolver                             373                         366
APC1 Holding(1)(3)                            Delayed Draw Term Loan                        -                         354
Aquavista Watersides 2 LTD(1)(2)(4)           Capex / Acquisition Facility              2,155                       2,543
Arc Education(1)(3)                           Delayed Draw Term Loan                    1,934                       1,900
Argus Bidco Limited(1)(2)(4)                  CAF Term Loan                               674                         789
Argus Bidco Limited(1)(2)(4)                  RCF Bridge Term Loan                        172                         168
ASC Communications, LLC                       Revolver                                  1,089                       1,089
Astra Bidco Limited(1)(4)                     Delayed Draw Term Loan                      901                         876
ATL II MRO Holdings, Inc.(1)                  Revolver                                  1,667                       1,667
Avance Clinical Bidco Pty Ltd(1)(5)           Delayed Draw Term Loan                    1,280                       1,295
Azalea Buyer, Inc.(1)                         Delayed Draw Term Loan                      962                         962
Azalea Buyer, Inc.(1)                         Revolver                                    481                         481
Bariacum S.A(1)(3)                            Acquisition Facility                      2,064                       2,028
Beyond Risk Management, Inc.(1)(2)            Delayed Draw Term Loan                    2,423                       2,423
Biolam Group(1)(2)(3)                         Delayed Draw Term Loan                    4,152                       4,783
Black Angus Steakhouses, LLC(1)               Delayed Draw Term Loan                      417                         417
Bounteous, Inc.(1)(2)                         Delayed Draw Term Loan                    2,840                       2,840


                                      130

--------------------------------------------------------------------------------
Portfolio Company
($ in thousands)                              Investment Type                     March 31, 2023              December 31, 2022
Brightpay Limited(1)(2)(3)                    Delayed Draw Term Loan                      138                           135
BrightSign LLC(1)                             Revolver                                      -                         1,329
CAi Software, LLC(1)(2)                       Revolver                                    943                           943

Canadian Orthodontic Partners Corp.(1)(2)(6) Delayed Draw Term Loan

                 -                           110
Catawba River Limited(1)(2)(4)                Structured Junior Note                   12,999                        12,635
Centralis Finco S.a.r.l.(1)(3)                Incremental CAF Term Loan                   921                         1,028
CGI Parent, LLC(1)(2)                         Revolver                                  1,653                         1,653

Classic Collision (Summit Buyer, LLC)(1) Delayed Draw Term Loan


               78                            78
Comply365, LLC(1)                             Revolver                                  1,101                           935
Coyo Uprising GmbH(1)(3)                      Delayed Draw Term Loan                      427                           419
CSL Dualcom(1)(4)                             Capex / Acquisition Term Loan               146                           142
DataServ Integrations, LLC(1)                 Revolver                                    481                           481
DecksDirect, LLC(1)                           Revolver                                    218                           218
DISA Holdings Corp.(1)                        Delayed Draw Term Loan                    1,368                         1,368
DISA Holdings Corp.(1)                        Revolver                                    429                           416
DreamStart Bidco SAS (d/b/a
SmartTrade)(1)(2)(3)                          Acquisition Facility                          -                           579
Dune Group(1)(2)(3)                           Delayed Draw Term Loan                      635                           624
Dwyer Instruments, Inc.(1)                    Delayed Draw Term Loan                    5,165                         5,164
Eclipse Business Capital, LLC(1)              Revolver                                 18,364                        17,455
EMI Porta Holdco LLC(1)(2)                    Delayed Draw Term Loan                    9,272                         9,272
EMI Porta Holdco LLC(1)(2)                    Revolver                                  1,092                         1,471
EPS NASS Parent, Inc.(1)                      Delayed Draw Term Loan                      257                           257
eShipping, LLC(1)                             Delayed Draw Term Loan                    1,650                         1,650
eShipping, LLC(1)                             Revolver                                  1,486                         1,486
Eurofins Digital Testing International LUX
Holding SARL(1)(2)(3)                         Delayed Draw Term Loan                    2,686                         2,639
Eurofins Digital Testing International LUX
Holding SARL(1)(2)(3)                         Delayed Draw Term Loan                      537                           528
Events Software BidCo Pty Ltd(1)(2)           Delayed Draw Term Loan                      640                           640
Express Wash Acquisition Company, LLC(1)(2)   Revolver                                    115                           115
F24 (Stairway BidCo GmbH)(1)(2)(3)            Acquisition Term Loan                       230                           246
Faraday(1)(2)(3)                              Delayed Draw Term Loan                      974                             -
Fineline Technologies, Inc.(1)                Delayed Draw Term Loan                        -                           180
Footco 40 Limited(1)(2)(4)                    Delayed Draw Term Loan                      556                           766
Fortis Payment Systems, LLC(1)(2)             Delayed Draw Term Loan                      925                           925
FragilePak LLC(1)                             Delayed Draw Term Loan                    2,354                         2,354
GB Eagle Buyer, Inc.(1)(2)                    Revolver                                  2,581                         2,581
Global Academic Group Limited(1)(7)           Term Loan                                   446                           451
GPZN II GmbH(1)(2)(3)                         CAF Term Loan                                 -                           560
Greenhill II BV(1)(3)                         Capex Acquisition Facility                  260                           255
Groupe Product Life(1)(3)                     Delayed Draw Term Loan                      449                           441
Gusto Aus BidCo Pty Ltd(1)(5)                 Delayed Draw Term Loan                      220                           223
HeartHealth Bidco Pty Ltd(1)(5)               Delayed Draw Term Loan                      309                           313

Heartland Veterinary Partners, LLC(1) Delayed Draw Term Loan

               267                           267
Heavy Construction Systems Specialists,
LLC(1)                                        Revolver                                  2,632                         2,632
HEKA Invest(1)(2)(3)                          Delayed Draw Term Loan                      565                           555
HTI Technology & Industries(1)(2)             Delayed Draw Term Loan                    2,045                         2,045


                                      131
--------------------------------------------------------------------------------


Portfolio Company
($ in thousands)                            Investment Type                     March 31, 2023              December 31, 2022
HTI Technology & Industries(1)(2)           Revolver                                  1,364                         1,364

HW Holdco, LLC (Hanley Wood LLC)(1) Delayed Draw Term Loan


            556                           913
Innovad Group II BV(1)(2)(3)                Delayed Draw Term Loan                    1,284                         1,261
INOS 19-090 GmbH(1)(3)                      Acquisition Facility                      2,422                         2,380
Interstellar Group B.V.(1)(3)               Delayed Draw Term Loan                    1,334                         1,310
Interstellar Group B.V.(1)(3)               Delayed Draw Term Loan                       56                            55
Isolstar Holding NV (IPCOM)(1)(3)           Delayed Draw Term Loan                      757                           744
ITI Intermodal, Inc.(1)(2)                  Delayed Draw Term Loan                        -                           103
ITI Intermodal, Inc.(1)(2)                  Delayed Draw Term Loan                    4,249                             -
ITI Intermodal, Inc.(1)(2)                  Revolver                                    857                           118
Jaguar Merger Sub Inc.(1)                   Delayed Draw Term Loan                        -                           422
Jaguar Merger Sub Inc.(1)                   Revolver                                      -                           490
Jocassee Partners LLC                       Joint Venture                            65,000                        65,000
Jon Bidco Limited(1)(7)                     Capex & Acquisition Facility              1,425                         1,441
Jones Fish Hatcheries & Distributors
LLC(1)(2)                                   Revolver                                    418                           418
Kano Laboratories LLC(1)                    Delayed Draw Term Loan                      153                           153
Kano Laboratories LLC(1)                    Delayed Draw Term Loan                    2,830                         2,830
Kemmerer Operations LLC(1)                  Delayed Draw Term Loan                        -                           908
Lambir Bidco Limited(1)(2)(3)               Delayed Draw Term Loan                    1,797                         1,766

Lattice Group Holdings Bidco Limited(1)(2) Delayed Draw Term Loan

             255                           298
LeadsOnline, LLC(1)                         Revolver                                  2,603                         2,603
Lifestyle Intermediate II, LLC(1)(2)        Revolver                                  2,500                         2,500
LivTech Purchaser, Inc.(1)(2)               Delayed Draw Term Loan                      138                           138
Marmoutier Holding B.V.(1)(2)(3)            Delayed Draw Term Loan                       24                            24
Marmoutier Holding B.V.(1)(2)(3)            Revolver                                    108                           106
Marshall Excelsior Co.(1)                   Revolver                                     55                           413
MC Group Ventures Corporation(1)            Delayed Draw Term Loan                      296                           296
Mercell Holding AS(1)(8)                    Capex Acquisition Facility                  750                           797
Modern Star Holdings Bidco Pty
Limited(1)(2)(5)                            Term Loan                                   956                           968
Murphy Midco Limited(1)(2)(4)               Delayed Draw Term Loan                      361                           407
Narda Acquisitionco., Inc.(1)(2)            Revolver                                  1,180                         1,180
NeoxCo(1)(2)(3)                             Delayed Draw Term Loan                      489                             -
Nexus Underwriting Management
Limited(1)(2)(4)                            Acquisition Facility                        374                           443
NF Holdco, LLC(1)(2)                        Revolver                                  1,105                             -
Novotech Aus Bidco Pty Ltd(1)(2)            Capex & Acquisition Facility                809                           809
NPM Investments 28 BV(1)(3)                 Delayed Draw Term Loan                      471                           463
OA Buyer, Inc.(1)                           Revolver                                  1,331                         1,331
OAC Holdings I Corp(1)                      Revolver                                    254                           607

Omni Intermediate Holdings, LLC(1)(2) Delayed Draw Term Loan

               -                         2,289
OSP Hamilton Purchaser, LLC(1)(2)           Revolver                                    384                           187
PDQ.Com Corporation(1)                      Delayed Draw Term Loan                    6,885                         6,885
Polara Enterprises, L.L.C.(1)               Revolver                                    545                           545
Premium Invest(1)(3)                        Delayed Draw Term Loan                    2,933                         2,882
ProfitOptics, LLC(1)                        Revolver                                    306                           484
Protego Bidco B.V.(1)(2)(3)                 Delayed Draw Term Loan                      807                           792
PSP Intermediate 4, LLC(1)(2)(3)            Delayed Draw Term Loan                      740                           727
Qualified Industries, LLC(1)(2)             Revolver                                    242                             -


                                      132
--------------------------------------------------------------------------------
Portfolio Company
($ in thousands)                                 Investment Type                          March 31, 2023              December 31, 2022
R1 Holdings, LLC(1)                              Delayed Draw Term Loan                         1,820                         2,623
R1 Holdings, LLC(1)                              Revolver                                       1,601                         1,601
RA Outdoors, LLC(1)(2)                           Revolver                                         864                         1,235
Randys Holdings, Inc.(1)(2)                      Delayed Draw Term Loan                         4,412                         4,412
Randys Holdings, Inc.(1)(2)                      Revolver                                       1,513                         1,571
Rep Seko Merger Sub LLC(1)                       Delayed Draw Term Loan                           579                           725
Reward Gateway (UK) Ltd(1)(2)(4)                 Acquisition Facility                             617                           600
Rhondda Financing No. 1 DAC(1)(2)(4)             Structured Junior Note                        22,914                             -
Rocade Holdings LLC                              Preferred Equity                              40,000                             -
Royal Buyer, LLC(1)                              Revolver                                       1,340                         1,340
Royal Buyer, LLC(1)                              Delayed Draw Term Loan                         2,082                         2,209
RTIC Subsidiary Holdings, LLC(1)(2)              Revolver                                       1,587                         2,381
Sanoptis S.A.R.L.(1)(2)(3)                       Acquisition Capex Facility                       846                         1,751
Sanoptis S.A.R.L.(1)(2)(9)                       CAF Delayed Draw Term Loan                       445                             -
SBP Holdings LP(1)(2)                            Delayed Draw Term Loan                         1,469                             -
SBP Holdings LP(1)(2)                            Revolver                                         887                             -
Scaled Agile, Inc.(1)(2)                         Delayed Draw Term Loan                           416                           416
Scaled Agile, Inc.(1)                            Revolver                                         336                           336
Scout Bidco B.V.(1)(3)                           Delayed Draw Term Loan                         2,311                         2,270
Scout Bidco B.V.(1)(3)                           Revolver                                       1,049                         1,030
Security Holdings B.V.(1)(2)(3)                  Delayed Draw Term Loan                         2,173                         2,134
Security Holdings B.V.(1)(2)(3)                  Revolver                                       1,086                         1,067
Sereni Capital NV(1)(2)(3)                       Delayed Draw Term Loan                         1,599                             -
Sereni Capital NV(1)(2)(3)                       Term Loan                                          -                           109
Smartling, Inc.(1)(2)                            Delayed Draw Term Loan                         1,978                         1,978
Smartling, Inc.(1)(2)                            Revolver                                       1,176                         1,176
Smile Brands Group, Inc.(1)(2)                   Delayed Draw Term Loan                             -                            38
Soho Square III Debtco II SARL(1)(4)             Delayed Draw Term Loan                         3,478                         3,383
Solo Buyer, L.P.(1)(2)                           Revolver                                       1,995                         1,995
Sparus Holdings, LLC (f/k/a Sparus Holdings,
Inc.)(1)                                         Delayed Draw Term Loan                           399                           666
Sparus Holdings, LLC (f/k/a Sparus Holdings,
Inc.)(1)                                         Revolver                                         141                           156
Spatial Business Systems LLC(1)                  Delayed Draw Term Loan                         7,500                         7,500
Spatial Business Systems LLC(1)                  Revolver                                       1,406                         1,406
SSCP Pegasus Midco Limited(1)(4)                 Delayed Draw Term Loan                         4,794                         4,664
Superjet Buyer, LLC(1)                           Revolver                                       1,825                         1,825
Syntax Systems Ltd(1)(2)                         Delayed Draw Term Loan                         1,933                         1,933
Syntax Systems Ltd(1)(2)                         Revolver                                         202                           337
Tank Holding Corp(1)                             Revolver                                         625                           698
Tanqueray Bidco Limited(1)(2)(4)                 Capex Facility                                 1,118                         1,088
Techone B.V.(1)(3)                               Revolver                                         310                           203
Tencarva Machinery Company, LLC(1)               Revolver                                       1,129                         1,129
The Caprock Group, Inc. (aka TA/TCG Holdings,
LLC)(1)                                          Delayed Draw Term Loan                         2,811                         2,811
The Caprock Group, Inc. (aka TA/TCG Holdings,
LLC)(1)                                          Revolver                                         827                           827
The Cleaver-Brooks Company, Inc.(1)              Revolver                                       3,229                         2,826
The Hilb Group, LLC(1)(2)                        Delayed Draw Term Loan                           858                         1,182
Trader Corporation(1)(6)                         Revolver                                         345                           345
TSYL Corporate Buyer, Inc.(1)                    Delayed Draw Term Loan                         1,681                         1,681


                                      133

--------------------------------------------------------------------------------



Portfolio Company                                                                                         December 31,
($ in thousands)                                Investment Type                   March 31, 2023              2022
TSYL Corporate Buyer, Inc.(1)                   Revolver                                    177                   177
Turbo Buyer, Inc.(1)(2)                         Delayed Draw Term Loan                    1,350                 1,350
Union Bidco Limited(1)(2)(4)                    Acquisition Facility                         80                    78

United Therapy Holding III GmbH(1)(2)(3) Acquisition Facility

                 672                 1,170
Unither (Uniholding)(1)(2)(3)                   Delayed Draw Term Loan                      471                     -
USLS Acquisition, Inc.(f/k/a US Legal Support,
Inc.)(1)(2)                                     Delayed Draw Term Loan                    3,629                 3,629
W2O Holdings, Inc.(1)                           Delayed Draw Term Loan                        -                 2,622
Waccamaw River(2)                               Joint Venture                             2,480                 2,480
Whitcraft Holdings, Inc.(1)(2)                  Revolver                                  1,886                     -
Woodland Foods, Inc.(1)(2)                      Line of Credit                              456                   456
WWEC Holdings III Corp(1)(2)                    Delayed Draw Term Loan                    3,106                 3,106
WWEC Holdings III Corp(1)(2)                    Revolver                                  1,367                 1,366
Xeinadin Bidco Limited(1)(2)(4)                 CAF Term Loan                             3,196                 3,109
ZB Holdco LLC(1)(2)                             Delayed Draw Term Loan                        -                 1,352
ZB Holdco LLC(1)                                Revolver                                    845                   845
Zeppelin Bidco Limited(1)(2)(4)                 Capex / Acquisition Facility              2,587                 2,516
Total unused commitments to extend financing                                

$ 371,795 $ 308,532




(1)The Adviser's estimate of the fair value of the current investments in these
portfolio companies includes an analysis of the fair value of any unfunded
commitments.
(2)Represents a commitment to extend financing to a portfolio company where one
or more of our current investments in the portfolio company are carried at less
than cost.
(3)Actual commitment amount is denominated in Euros. Commitment was translated
into U.S. dollars based on the spot rate at the relevant balance sheet date.
(4)Actual commitment amount is denominated in British pounds sterling.
Commitment was translated into U.S. dollars based on the spot rate at the
relevant balance sheet date.
(5)Actual commitment amount is denominated in Australian dollars. Commitment was
translated into U.S. dollars based on the spot rate at the relevant balance
sheet date.
(6)Actual commitment amount is denominated in Canadian dollars. Commitment was
translated into U.S. dollars based on the spot rate at the relevant balance
sheet date.
(7)Actual commitment amount is denominated in New Zealand dollars. Commitment
was translated into U.S. dollars based on the spot rate at the relevant balance
sheet date.
(8)Actual commitment amount is denominated in Norwegian kroner. Commitment was
translated into U.S. dollars based on the spot rate at the relevant balance
sheet date.
(9)Actual commitment amount is denominated in Swiss francs. Commitment was
translated into U.S. dollars based on the spot rate at the relevant balance
sheet date.

In the normal course of business, we guarantee certain obligations in connection
with our portfolio companies (in particular, certain controlled portfolio
companies). Under these guarantee arrangements, payments may be required to be
made to third parties if such guarantees are called upon or if the portfolio
companies were to default on their related obligations, as applicable. As of
March 31, 2023 and December 31, 2022, we had guaranteed €9.9 million
($10.8 million U.S. dollars and $10.6 million U.S. dollars, respectively)
relating to credit facilities among Erste Bank and MVC Automotive Group Gmbh, or
MVC Auto that mature in December 2025. We would be required to make payments to
Erste Bank if MVC Auto were to default on their related payment obligations.
None of the credit facility guarantees are recorded as a liability on our
Unaudited and Audited Consolidated Balance Sheets. As such, the credit facility
liabilities are considered in the valuation of our investments in MVC Auto. The
guarantees denominated in foreign currencies were translated into U.S. dollars
based on the spot rate at the relevant balance sheet date.

© Edgar Online, source Glimpses